Literature DB >> 18940301

Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia).

Imen Trabelsi1, Sofiene Rekik, Abir Znazen, Imed Maaloul, Dorra Abid, Abdelkader Maalej, Ilyes Kharrat, Mounir Ben Jemaa, Adnane Hammemi, Samir Kammoun.   

Abstract

The aim of the study was to describe the epidemiological and clinical aspects of native valve infective endocarditis (IE) in a Tunisian high-volume tertiary care center and to identify the predictors of outcome. Demographic, clinical, laboratory, and echocardiographic characteristics were examined in 134 patients who fulfilled the modified Duke criteria for native valve IE between January 1997 and December 2006. Logistic regression analysis was used to identify prognostic factors for death. Mean age was 34.22 years. Diagnosis was definite in 93% of cases. Median time to diagnosis was 21 days. Rheumatic heart disease (RHD) was the predominant (45%) underlying heart condition. One or more vegetations were detected in more than 93% of cases. The median size of vegetation was >15 mm in 28% of cases. In 66 cases (49%), cultures remained negative. Serology was positive in 15 cases, and in 4 cases leaflet culture identified the agent. The infective agent was identified in 87 cases (65%), causative microorganisms were mainly Staphylococci (n = 30, including 6 coagulase-negative Staphylococcus), and Streptococci (n = 32). Overall mortality was 19%. On multivariate analysis, congestive heart failure (hazard ratio = 5.34, 95% confidence interval 1.67 to 17.15, p = 0.005) and large vegetations (>15 mm; hazard ratio = 5.78, 95% confidence interval 1.84 to 18.32, p = 0.002) were predictive of in-hospital mortality but not neurological complications or staphylococcus IE. In conclusion, IE remains a serious disease affecting a young population in Tunisia, with RHD as still the most common underlying heart disease, and it is associated with a high mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18940301     DOI: 10.1016/j.amjcard.2008.06.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines.

Authors:  Daniel C Desimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Circulation       Date:  2012-06-11       Impact factor: 29.690

2.  Global trends in infective endocarditis epidemiology.

Authors:  Haur Sen Yew; David R Murdoch
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 3.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

Authors:  Daniel C DeSimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Am Heart J       Date:  2015-07-17       Impact factor: 4.749

5.  Infective endocarditis in Rio de Janeiro, Brazil: a 5-year experience at two teaching hospitals.

Authors:  P V Damasco; J N Ramos; J C D Correal; M V Potsch; V V Vieira; T C F Camello; M P Pereira; V D Marques; K R N Santos; E A Marques; M B Castier; R Hirata; A L Mattos-Guaraldi; C Q Fortes
Journal:  Infection       Date:  2014-06-17       Impact factor: 3.553

6.  Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis.

Authors:  Sofiene Rekik; Imen Trabelsi; Mourad Hentati; Adnene Hammami; Mounir Ben Jemaa; Jamil Hachicha; Samir Kammoun
Journal:  Clin Exp Nephrol       Date:  2009-04-21       Impact factor: 2.801

Review 7.  Surgery in current therapy for infective endocarditis.

Authors:  Stuart J Head; M Mostafa Mokhles; Ruben L J Osnabrugge; Ad J J C Bogers; A Pieter Kappetein
Journal:  Vasc Health Risk Manag       Date:  2011-04-19

8.  Impact of routine cerebral CT angiography on treatment decisions in infective endocarditis.

Authors:  Marwa Sayed Meshaal; Hussein Heshmat Kassem; Ahmad Samir; Ayman Zakaria; Yasser Baghdady; Hussein Hassan Rizk
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  Infective endocarditis at a hospital in Saudi Arabia: epidemiology, bacterial pathogens and outcome.

Authors:  Jaffar A Al-Tawfiq; Ismail Sufi
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

10.  Infective endocarditis in northeastern Thailand.

Authors:  George Watt; Orathai Pachirat; Henry C Baggett; Susan A Maloney; Viraphong Lulitanond; Didier Raoult; Saithip Bhengsri; Somsak Thamthitiwat; Anucha Paupairoj; Michael Kosoy; Nongrak Ud-Ai; Wichuda Sukwicha; Toni Whistler; Pierre-Edouard Fournier
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.